One of China's oldest personal-care companies, selling skincare, baby care and household brands including Herborist and Liushen.
One of China's oldest personal-care companies, selling skincare, baby care and household brands including Herborist and Liushen.
In one line: A legacy Chinese personal-care conglomerate.
Moat: narrow (brand). Century-old heritage brands though losing share to faster-growing domestic and multinational rivals.
Headquarters: Shanghai, China · Founded: 1898 · Employees: 3,173
Size Shanghai Jahwa United (600315.SS) is a China Consumer Staples company (Household/Personal Care) with a market value of $1.61B, the 1417th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥16.25 on 18 Nov 2026.
Performance Over six months the shares fell 14.7%, against +7.1% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 9.0% over the last twelve months (peer median +5.6%); the operating margin is 2.2% (peer median 10.5%).
Valuation It trades at 15.4× forward earnings against a peer median of 19.0× (10th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is -2%, so the hurdle is +17 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.7 points below its cost of capital (8.5% WACC).
Next results Next results expected around 12 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥6.72B | CN¥6.28B | CN¥5.65B | CN¥6.56B | CN¥7.07B |
| Revenue growth | — | +11% | -14% | -7% | — |
| Gross profit | CN¥4.40B | CN¥3.77B | CN¥3.10B | CN¥3.71B | CN¥3.87B |
| EBITDA | n/a | CN¥299M | CN¥68.6M | CN¥485M | CN¥757M |
| Net income | CN¥669M | CN¥268M | -CN¥833M | CN¥500M | CN¥472M |
| Free cash flow | CN¥496M | CN¥902M | CN¥261M | CN¥114M | CN¥760M |
| Capital expenditure | CN¥87.3M | CN¥76.8M | CN¥96.2M | CN¥119M | CN¥114M |
| Total debt | CN¥483M | CN¥603M | CN¥662M | CN¥967M | CN¥1.17B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Shanghai Jahwa United 600315.SS | $1.61B | -15% | +9% | 2% | 15.4× | 15.3% |
| Proya Cosmetics 603605.SS | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% |
| Yunnan Botanee Bio-Technology 300957.SZ | $1.69B | -33% | +7% | 9% | 19.1× | 2.6% |
| Unilever ULVR.L | $139B | +15% | -20% | 20% | 18.2× | 8.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 600315.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -11.0% | +2.2% | 4th lowest of 21 |
| 6-month return | -14.7% | +7.1% | 7th lowest of 21 |
| Distance from 52-week high | -34.9% | -24.8% | 8th lowest of 21 |
| Revenue growth (TTM) | +9.0% | +5.6% | 8th highest of 21 |
| Operating margin | 2.2% | 10.5% | 3rd lowest of 21 |
| Forward P/E | 15.4× | 19.0× | 10th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | 15.3% | 0.5% | 4th most demanding of 17 |
| Growth delivered (Del g) | -2.1% | +13.4% | lowest of 17 |
| Hurdle (Req g minus delivered) | +17.4 pp | -5.9 pp | most demanding of 17 |
| ROIC minus cost of capital | -3.7 pp | +6.8 pp | 2nd lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shanghai Jahwa United 600315.SS | China | $1.61B | -15% | +9% | 2% | 15.4× | 15.3% | -2.1% |
| AMOREPACIFIC 002790.KS | South Korea | $1.61B | +2% | +9% | 9% | 8.5× | -5.7% | -1.3% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.62B | +9% | -6% | 2% | 45.5× | n/a | n/a |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.69B | -33% | +7% | 9% | 19.1× | 2.6% | +15.3% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.51B | -39% | +28% | 20% | 21.4× | 7.5% | +3.6% |
| Pigeon 7956.T | Japan | $1.76B | +26% | +8% | 13% | 27.9× | -2.4% | +1.9% |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| Energizer ENR | United States | $1.94B | +71% | 0% | 17% | 9.1× | -5.1% | -0.5% |
| Emami EMAMILTD.NS | India | $1.94B | -5% | +13% | 20% | 23.4× | 21.5% | +5.6% |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Pola Orbis 4927.T | Japan | $2.04B | +15% | +1% | 11% | 30.6× | -2.0% | -0.7% |
| Kolmar Korea 161890.KS | South Korea | $2.05B | +14% | +16% | 10% | 14.3× | -1.6% | +15.5% |
| Blue Moon 6993.HK | Hong Kong | $2.07B | -4% | -2% | -2% | 103.3× | n/a | n/a |
| KOSE 4922.T | Japan | $2.16B | +16% | +4% | 5% | 29.9× | n/a | n/a |
| Softcare 2698.HK | Hong Kong | $2.20B | +5% | +25% | 25% | 14.4× | 9.1% | +20.9% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.37B | -30% | -2% | 24% | 27.0× | 21.2% | +7.4% |
| Giant Biogene 2367.HK | Hong Kong | $2.47B | -32% | -10% | 32% | 8.6× | -10.7% | +34.9% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |